The molecular basis of genetic lipodystrophies

Clinical Biochemistry

Volumn 35, Issue 3, 2002, Pages 171-177

  Bhayana, Shelly ^a   Hegele, Robert A ^a  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

Author keywords

Adipose tissue; Complex trait; Diabetes; Insulin; Obesity; Syndrome X

Indexed keywords

ADIPOSE TISSUE; ANIMAL; CLASSIFICATION; CONGENITAL MALFORMATION; DISEASE MODEL; GENETICS; HUMAN; HYPERINSULINISM; LIPODYSTROPHY; METABOLISM; MUTATION; PATHOLOGY; PHENOTYPE; REVIEW; DISEASE CLASSIFICATION; DISEASE COURSE; GENETIC HETEROGENEITY; HYPERINSULINEMIA; HYPERLIPIDEMIA; INSULIN RESISTANCE; MOLECULAR GENETICS; NONHUMAN; PRIORITY JOURNAL;

ADIPOSE TISSUE; ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; HYPERINSULINISM; LIPODYSTROPHY; MUTATION; PHENOTYPE; ANIMAL; HUMAN; HYPERINSULINEMIA; SUPPORT, NON-U.S. GOV'T;

TROGLITAZONE;

EID: 0036017349     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9120(02)00297-7     Document Type: Review

References (79)

1. Pathophysiology of insulin resistance in human disease
2. Insulin resistance and human disease: A short history
3. Lipodystrophy and hepatomegaly with diabetes, lipaemia, and other metabolic disturbances: A case throwing new light on the action of insulin
4. Partial lipodystrophy and renal disease
5. Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance
6. Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy
7. Myocardial infarction in HIV-infected men receiving protease inhibitors
8. A new genetic variety of lipodystrophy
9. Familial lipoatrophic diabetes with dominant transmission: A new syndrome
10. Familial partial lipodystrophy: Two types of an X linked dominant syndrome, lethal in the hemizygous state
11. Partial lipoatrophy with insulin resistant diabetes and hyperlipidaemia (Dunnigan syndrome)
12. Adipose tissue distribution pattern in patients with familial partial lipodystrophy (Dunnigan variety)
13. Localization of the gene for familial partial lipodystrophy (Dunnigan variety) to chromosome 1q21-22
14. A defect in the regional deposition of adipose tissue (partial lipodystrophy) is encoded by a gene at chromosome 1q
15. Confirmation of linkage of hereditary partial lipodystrophy to chromosome 1q21-22
16. Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy
17. Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease
18. Identification of mutations in the gene encoding lamins A/C in autosomal dominant limb girdle muscular dystrophy with atrioventricular conduction disturbances (LGMD1B)
19. Nuclear lamin A/C R482Q mutation in Canadian kindreds with Dunnigan-type familial partial lipodystrophy
20. Lamin A/C mutation in a woman, and her two daughters with Dunnigan-type partial lipodystrophy
21. LMNA, encoding lamin A/C, is mutated in partial lipodystrophy
22. Mutational and haplotype analyses of families with familial partial lipodystrophy (Dunnigan variety) reveal recurrent missense mutations in the globular C-terminal domain of lamin A/C
23. Heterogeneity of nuclear lamin A mutations in Dunnigan-type familial partial lipodystrophy
24. Mutations in the LMNA gene encoding lamin A/C
25. Association between nuclear lamin A/C R482Q mutation and partial lipodystrophy with hyperinsulinemia, dyslipidemia, hypertension and diabetes
26. Premature atherosclerosis associated with monogenic insulin resistance
27. LMNA R482Q mutation in partial lipodystrophy associated with reduced plasma leptin concentration
28. Nuclear lamins: Their structure, assembly and interactions
29. CDNA sequencing of nuclear lamins A, and C reveals primary, and secondary structural homology to intermediate filament proteins
30. Heart to heart: From nuclear proteins to Emery-Dreifuss muscular dystrophy
31. The envelope, please: Nuclear lamins and disease
32. Pushing the envelope on lipodystrophy
33. An undiagnosed endocrinometabolic syndrome: Report of 2 cases
34. Lipodysrophy and gigantism with associated endocrine manifestation
35. Generalized lipodystrophy
36. Peculiar distribution of adipose tissue in patients with congenital generalized lipodystrophy
37. Generalized lipodystrophy, congenital and acquired (lipoatrophy)
38. The skeleton in congenital, generalized lipodystrophy: Evaluation using whole-body radiographic surveys, magnetic resonance imaging and technetium-99m bone scintigraphy
39. Congenital lipodystrophy: An endocrine study in three siblings
40. Congenital generalized lipodystrophy accompanied by cystic angiomatosis
41. Cardiac findings in generalized lipodystrophy
42. Echocardiographic assessment of cardiac function and morphology in patients with generalized lipodystrophy
43. Hypertrophic cardiomyopathy in total lipodystrophy
44. Cardiac involvement in total generalized lipodystrophy
45. Postmortem findings in congenital generalized lipodystrophy
46. Severe islet amyloidosis in congenital generalized lipodystrophy
47. A gene for congenital generalized lipodystrophy maps to human chromosome 9q34
48. Single nucleotide polymorphisms of RXRA encoding retinoid X receptor alpha
49. Identification of the gene altered in Berardinelli-Seip congenital lipodystrophy on chromosome 11q13
50. Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor
51. Regulation of adipocyte gene expression and differentiation by peroxisome proliferator activated receptor gamma
52. Efficacy and safety of troglitazone in the treatment of lipodystrophy syndromes
53. Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: Model for congenital generalized lipodystrophy
54. Life without white fat: A transgenic mouse
55. Targeted expression of a toxin gene to adipose tissue: Transgenic mice resistant to obesity
56. Insulin resistance in total lipodystrophy: Evidence for a pre-receptor defect in insulin action
57. In vivo and vitro characterization of insulin resistance in three cases of lipoatrophic diabetes
58. Normal insulin binding to cultured fibroblasts from patients with lipoatrophic diabetes
59. Cell culture studies of a patient with congenital lipoatrophic diabetes: Normal insulin binding with alterations in intra-cellular glucose metabolism and insulin action
60. Insulin receptor evaluation in congenital generalized lipodystrophy
61. In vitro studies of insulin resistance in patients with lipoatrophic diabetes
62. Decreased binding of insulin to its receptor in patients with congenital generalized lipodystrophy
63. Binding of insulin to fibroblasts in lipoatrophic diabetes
64. Congenital generalized lipodystrophy with insulin-resistant diabetes
65. Heterogeneity of the insulin-receptor interaction in lipoatrophic diabetes
66. Insulin resistance in a boy with congenital generalized lipodystrophy
67. Altered expression and function of the insulin receptor in a family with lipoatrophic diabetes
68. Patients with lipodystrophic diabetes mellitus of the Seip-Berardinelli type, express normal insulin receptors
69. Mechanism of insulin resistance in A-ZIP/F-1 fatless mice
70. Insulin inhibits transcription of IRS-2 gene in rat liver through an insulin response element (IRE) that resembles IREs of other insulin-repressed genes
71. Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice
72. Serum immunoreactive leptin concentrations in normal-weight and obese humans
73. Disease model: Hyperinsulinemia and insulin resistance
74. Leptin levels, B-cell function, and insulin sensitivity in families with congenital and acquired generalized lipoatrophic diabetes
75. Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy
76. Leptin and diabetes in lipoatrophic mice
77. Transgenic overexpression of leptin rescues insulin resistance and diabetes in a mouse model of lipoatrophic diabetes
78. Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice
79. The glucose fatty-acid cycle, its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus